Theravance Biopharma, Inc. — Director's Dealing 2016

Mar 18, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Theravance Biopharma, Inc. (TBPH)
CIK: 0001583107
Period of Report: 2016-03-15

Reporting Person: Mammen Mathai (SVP, Research & Development)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-03-15	Ordinary Shares	A	90000	—	Acquired	288111	Direct